🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study we are testing computer-based brain fitness exercises. The ga...
Status
Terminated
Location
NeuroCognitive Imaging Lab, Dalhousie University
Start Date
2013-01
Trial ID
NCT01732887
Treatments Being Tested
Among people with HIV, the severity of depressive symptoms has repeatedly b...
Status
Terminated
Location
McGill University Health Center
Start Date
2017-09-06
Trial ID
NCT03275571
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
This randomized phase III trial studies how well pazopanib hydrochloride wo...
Status
Active Not Recruiting
Location
Fairbanks Memorial Hospital
Start Date
2012-08-08
Trial ID
NCT01575548
Suicide prevention is a top priority for VA as all continue to seek new and...
Status
Recruiting
Location
Southeast Louisiana Veterans Health Care System, New Orleans, LA
Start Date
2024-01-08
Trial ID
NCT05884476
Treatments Being Tested
The goal of this clinical trial is to learn if adding brain stimulation (ce...
Status
Completed
Location
The University of Hong Kong
Start Date
2024-01-03
Trial ID
NCT07353879
This study is designed in two Phases. In phase 1, the Functional Outcome Me...
Status
Suspended
Location
NovaVision, Inc.
Start Date
2007-09
Trial ID
NCT00731796
Treatments Being Tested
This trial is an open-label, two-arm, cluster-randomized, controlled trial ...
Status
Completed
Location
Fuwai Hospital
Start Date
2020-11-27
Trial ID
NCT04328090
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713